Joseph A. Odin

5.6k total citations
69 papers, 2.4k citations indexed

About

Joseph A. Odin is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Joseph A. Odin has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 36 papers in Hepatology and 18 papers in Pharmacology. Recurrent topics in Joseph A. Odin's work include Liver Disease Diagnosis and Treatment (30 papers), Liver Diseases and Immunity (25 papers) and Drug-Induced Hepatotoxicity and Protection (17 papers). Joseph A. Odin is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Liver Diseases and Immunity (25 papers) and Drug-Induced Hepatotoxicity and Protection (17 papers). Joseph A. Odin collaborates with scholars based in United States, United Kingdom and France. Joseph A. Odin's co-authors include Antony Rosen, Livia Casciola‐Rosen, Robert C. Huebert, Nicholas F. LaRusso, Jorge Allina, Varun Kesar, Jay C. Unkeless, Carmen Stanca, Nancy Bach and Scott L. Friedman and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Joseph A. Odin

67 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph A. Odin United States 29 1.1k 1.0k 522 389 371 69 2.4k
Yoshikazu Murawaki Japan 35 1.8k 1.7× 1.7k 1.6× 1.0k 2.0× 782 2.0× 160 0.4× 196 4.1k
Harald Hofer Austria 32 3.0k 2.8× 2.7k 2.6× 217 0.4× 537 1.4× 280 0.8× 73 4.0k
Nicola De Maria Italy 32 1.9k 1.7× 1.8k 1.7× 574 1.1× 521 1.3× 194 0.5× 102 3.2k
Taku Naiki Japan 29 631 0.6× 718 0.7× 776 1.5× 599 1.5× 244 0.7× 183 2.6k
Ke‐Qin Hu United States 32 2.0k 1.8× 1.9k 1.9× 363 0.7× 515 1.3× 124 0.3× 102 3.1k
Gopal Krishna Dhali India 18 594 0.6× 1.0k 1.0× 372 0.7× 480 1.2× 188 0.5× 82 2.0k
Makoto Oketani Japan 24 1.2k 1.1× 1.1k 1.1× 248 0.5× 280 0.7× 175 0.5× 68 1.9k
Massimo Zuin Italy 39 2.5k 2.3× 2.3k 2.3× 309 0.6× 1.2k 3.1× 113 0.3× 142 4.2k
Urmila Khettry United States 27 1.1k 1.0× 1.1k 1.1× 368 0.7× 1.1k 2.9× 79 0.2× 76 2.8k
Meena B. Bansal United States 24 1.2k 1.1× 1.6k 1.6× 338 0.6× 379 1.0× 80 0.2× 73 2.5k

Countries citing papers authored by Joseph A. Odin

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Odin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Odin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Odin more than expected).

Fields of papers citing papers by Joseph A. Odin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Odin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Odin. The network helps show where Joseph A. Odin may publish in the future.

Co-authorship network of co-authors of Joseph A. Odin

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Odin. A scholar is included among the top collaborators of Joseph A. Odin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Odin. Joseph A. Odin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yi‐Ju, Jawad Ahmad, Huiman X. Barnhart, et al.. (2024). Clinical characteristics and HLA associations of azithromycin‐induced liver injury. Alimentary Pharmacology & Therapeutics. 60(6). 787–795. 7 indexed citations
2.
Nicoletti, Paola, Andrew Dellinger, Yi‐Ju Li, et al.. (2022). Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate. Gastroenterology. 164(3). 454–466. 25 indexed citations
3.
Pericleous, Marinos, Claire Kelly, Joseph A. Odin, et al.. (2020). Clinical Ontologies Improve Case Finding of Primary Biliary Cholangitis in UK Primary and Secondary Care. Digestive Diseases and Sciences. 65(11). 3143–3158. 2 indexed citations
4.
Bichoupan, Kian, Neeta Tandon, Valérie Martel‐Laferrière, et al.. (2017). Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection. World Journal of Hepatology. 9(11). 551–551. 1 indexed citations
5.
Torres, Joana, Xiuliang Bao, Aparna Goel, et al.. (2016). The features of mucosa‐associated microbiota in primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics. 43(7). 790–801. 111 indexed citations
6.
Ahmad, Jawad & Joseph A. Odin. (2016). Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity. Clinics in Liver Disease. 21(1). 55–72. 35 indexed citations
7.
Torres, Joana, Xiuliang Bao, Alina C. Iuga, et al.. (2013). Farnesoid X Receptor Expression Is Decreased in Colonic Mucosa of Patients with Primary Sclerosing Cholangitis and Colitis-associated Neoplasia. Inflammatory Bowel Diseases. 19(2). 275–282. 45 indexed citations
8.
Ala, Aftab, David J. Brown, Korsa Khan, et al.. (2013). Mucosal Addressin Cell Adhesion Molecule (MAdCAM-1) Expression Is Upregulated in the Cirrhotic Liver and Immunolocalises to the Peribiliary Plexus and Lymphoid Aggregates. Digestive Diseases and Sciences. 58(9). 2528–2541. 14 indexed citations
9.
Odin, Joseph A., et al.. (2008). Recent Advances in the Epidemiology of Primary Biliary Cirrhosis. Clinics in Liver Disease. 12(2). 289–303. 21 indexed citations
10.
Ward, Stephen, et al.. (2008). Cholestatic Liver Injury Associated with Whey Protein and Creatine Supplements. Seminars in Liver Disease. 28(2). 226–231. 28 indexed citations
11.
Allina, Jorge, Bin Hu, Daniel M. Sullivan, et al.. (2006). T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. Journal of Autoimmunity. 27(4). 232–241. 74 indexed citations
12.
Matsumura, Shuji, Judy Van de Water, Patrick S.C. Leung, et al.. (2004). Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology. 39(5). 1415–1422. 73 indexed citations
13.
Benzeno, Sharon, Goutham Narla, Jorge Allina, et al.. (2004). Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1. Cancer Research. 64(11). 3885–3891. 125 indexed citations
14.
Mao, Tin K., Paul A. Davis, Joseph A. Odin, Ross L. Coppel, & Eric M. Gershwin. (2004). Sidechain Biology and the Immunogenicity of Pdc–E2, the Major Autoantigen of Primary Biliary Cirrhosis. Hepatology. 40(6). 1241–1248. 38 indexed citations
15.
Sasaki, Motoko, Jorge Allina, Joseph A. Odin, et al.. (2002). Autoimmune Cholangitis in the SJL/J Mouse is Antigen Non‐specific. Journal of Immunology Research. 9(2). 103–111. 8 indexed citations
16.
Zhang, Fen, Bing Yang, Joseph A. Odin, et al.. (1995). Lateral mobility of FcγRIIa is reduced by protein kinase C activation. FEBS Letters. 376(1-2). 77–80. 16 indexed citations
17.
Boros, Péter, Joseph A. Odin, Jiezhong Chen, & Jay C. Unkeless. (1994). Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease.. The Journal of Immunology. 152(1). 302–306. 26 indexed citations
18.
Boutron, P., Jean‐Luc Descotes, G Fauré, et al.. (1993). Organ preservation at low temperature: a physical and biological problem. Journal de Physique I. 3(2). 515–531. 4 indexed citations
19.
Boros, Péter, Joseph A. Odin, Tai Muryoi, et al.. (1991). IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation.. The Journal of Experimental Medicine. 173(6). 1473–1482. 35 indexed citations
20.
Qu, Zhe, Joseph A. Odin, J. David Glass, & Jay C. Unkeless. (1988). Expression and characterization of a truncated murine Fc gamma receptor.. The Journal of Experimental Medicine. 167(3). 1195–1210. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshikazu Murawaki Breakdown of academic impact, for papers by Harald Hofer Breakdown of academic impact, for papers by Nicola De Maria Breakdown of academic impact, for papers by Taku Naiki Breakdown of academic impact, for papers by Ke‐Qin Hu Breakdown of academic impact, for papers by Gopal Krishna Dhali Breakdown of academic impact, for papers by Makoto Oketani Breakdown of academic impact, for papers by Massimo Zuin Breakdown of academic impact, for papers by Urmila Khettry Breakdown of academic impact, for papers by Meena B. Bansal
Rankless by CCL
2026